Get Premium to unlock powerful stock data
NAS:PCRX (USA)  
Pacira BioSciences Inc logo

Pacira BioSciences Inc

$ 57.85 -0.45 (-0.77%) 08:08 PM EST
P/E:
68.87
P/B:
3.67
Market Cap:
$ 2.63B
Enterprise V:
$ 3.18B
Volume:
436.02K
Avg Vol (2M):
497.80K
Also Trade In:
Volume:
436.02K
Market Cap $:
2.63B
PE Ratio:
68.87
Avg Vol (2-Month):
497.80K
Enterprise Value $:
3.18B
PB Ratio:
3.67
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Pacira BioSciences Inc
NAICS : 325412 SIC : 2834
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Description
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.
Name Current Vs Industry Vs History
Cash-To-Debt 0.45
Equity-to-Asset 0.38
Debt-to-Equity 1.41
Debt-to-EBITDA 7.92
Interest Coverage 4.2
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.9
Distress
Grey
Safe
Beneish M-Score -1.79
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 59.73
9-Day RSI 52.38
14-Day RSI 47.67
6-1 Month Momentum % 5.45
12-1 Month Momentum % 5.79

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.19
Quick Ratio 1.85
Cash Ratio 1.48
Days Inventory 201.05
Days Sales Outstanding 45.19
Days Payable 27.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.8

Financials (Next Earnings Date:2022-08-03 Est.)

PCRX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:PCRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 580.497
EPS (TTM) ($) 0.84
Beta 1.06
Volatility % 30.5
14-Day RSI 47.67
14-Day ATR ($) 2.454557
20-Day SMA ($) 56.8435
12-1 Month Momentum % 5.79
52-Week Range ($) 45.05 - 82.16
Shares Outstanding (Mil) 45.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pacira BioSciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More